2024
External Validation of an Electronic Health Record-Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis.
Moledina D, Shelton K, Menez S, Aklilu A, Yamamoto Y, Kadhim B, Shaw M, Kent C, Makhijani A, Hu D, Simonov M, O'Connor K, Bitzel J, Thiessen-Philbrook H, Wilson F, Parikh C. External Validation of an Electronic Health Record-Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis. Journal Of The American Society Of Nephrology 2024 PMID: 39500309, DOI: 10.1681/asn.0000000556.Peer-Reviewed Original ResearchJohns Hopkins HospitalAcute tubulointerstitial nephritisValidation cohortKidney biopsyTubulointerstitial nephritisDiagnosis of acute tubulointerstitial nephritisProportion of biopsiesElectronic health recordsAnalyzed patientsDevelopment cohortBaseline prevalenceAccurate diagnosisBiopsyCohortHealth recordsClinician's abilityDiagnostic modelPotential predictorsNephritisAssess discriminationKidneyAUCDevelopment of Urinalysis Screening Criteria for Electronic Health Alerts for Rhabdomyolysis
Yasmin F, Faulkner S, Aklilu A, Yamamoto Y, Moledina D, Wilson F. Development of Urinalysis Screening Criteria for Electronic Health Alerts for Rhabdomyolysis. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024bb8bw9yb. DOI: 10.1681/asn.2024bb8bw9yb.Peer-Reviewed Original ResearchEffect of Cessation of Renin-Angiotensin System Inhibitors on Clinical Outcomes in AKI
Makhijani A, Yasmin F, Moledina D, Yamamoto Y, Wilson F. Effect of Cessation of Renin-Angiotensin System Inhibitors on Clinical Outcomes in AKI. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024xcwjpmwx. DOI: 10.1681/asn.2024xcwjpmwx.Peer-Reviewed Original ResearchClinical Predictors of Fluid-Responsive AKI
Nguyen C, Aklilu A, Yamamoto Y, Coronel-Moreno C, Kadhim B, Wilson F. Clinical Predictors of Fluid-Responsive AKI. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024k7pcazfe. DOI: 10.1681/asn.2024k7pcazfe.Peer-Reviewed Original ResearchPersonalized Recommendations for AKI Using a Kidney Action Team: A Multicenter Randomized Controlled Trial
Aklilu A, Menez S, Yamamoto Y, Bitzel J, Villalobos C, O'Connor K, Shelton K, Faulkner S, Makhijani A, Kadhim B, Parikh C, Wilson F. Personalized Recommendations for AKI Using a Kidney Action Team: A Multicenter Randomized Controlled Trial. Journal Of The American Society Of Nephrology 2024, 35: 10.1681/asn.2024gjjnbwvc. DOI: 10.1681/asn.2024gjjnbwvc.Peer-Reviewed Original ResearchPromoting Collaborative Scholarship During the COVID-19 Pandemic Through an Innovative COVID-19 Data Explorer and Repository at Yale School of Medicine: Development and Usability Study
Victoria-Castro A, Arora T, Simonov M, Biswas A, Alausa J, Subair L, Gerber B, Nguyen A, Hsiao A, Hintz R, Yamamoto Y, Soufer R, Desir G, Wilson F, Villanueva M. Promoting Collaborative Scholarship During the COVID-19 Pandemic Through an Innovative COVID-19 Data Explorer and Repository at Yale School of Medicine: Development and Usability Study. JMIR Formative Research 2024, 8: e52120. PMID: 39226547, PMCID: PMC11408881, DOI: 10.2196/52120.Peer-Reviewed Original ResearchPragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial
Shah N, Ghazi L, Yamamoto Y, Kumar S, Martin M, Simonov M, Riello Iii R, Faridi K, Ahmad T, Wilson F, Desai N. Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial. Circulation Cardiovascular Quality And Outcomes 2024, 17: e010335. PMID: 38634282, DOI: 10.1161/circoutcomes.123.010335.Peer-Reviewed Original ResearchElectronic health recordsElectronic health record alertsHigh-risk atherosclerotic cardiovascular diseaseLipid lowering therapyAtherosclerotic cardiovascular diseasePragmatic trialCardiovascular diseaseProportion of patientsYale New Haven HealthLDL-CSecondary outcomesPrimary outcomeInternal medicine cliniciansEHR alertUsual careHealth recordsProvider levelCluster-randomizedLDL-C managementLDL-C levelsAdverse cardiovascular eventsRandomized clinical trialsTreatment of hyperlipidemiaCliniciansCardiovascular eventsELECTRONIC ALERTS TO IMPROVE MINERALOCORTICOID RECEPTOR ANTAGONIST USE AND HYPERKALEMIA MANAGEMENT IN AMBULATORY PATIENTS WITH HEART FAILURE: A CLUSTER RANDOMIZED TRIAL
Clark K, Victoria-Castro A, Ghazi, Yamamoto Y, Coronel-Moreno C, Kadhim B, Riello R, O'Connor K, Ahmad T, Wilson F, Desai N. ELECTRONIC ALERTS TO IMPROVE MINERALOCORTICOID RECEPTOR ANTAGONIST USE AND HYPERKALEMIA MANAGEMENT IN AMBULATORY PATIENTS WITH HEART FAILURE: A CLUSTER RANDOMIZED TRIAL. Journal Of The American College Of Cardiology 2024, 83: 2395. DOI: 10.1016/s0735-1097(24)04385-7.Peer-Reviewed Original ResearchCOVID-19−Associated Acute Kidney Injury and Longitudinal Kidney Outcomes
Aklilu A, Kumar S, Nugent J, Yamamoto Y, Coronel-Moreno C, Kadhim B, Faulkner S, O’Connor K, Yasmin F, Greenberg J, Moledina D, Testani J, Wilson F. COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney Outcomes. JAMA Internal Medicine 2024, 184: 414-423. PMID: 38407862, PMCID: PMC10897825, DOI: 10.1001/jamainternmed.2023.8225.Peer-Reviewed Original ResearchCOVID-19-associated acute kidney injuryCOVID-19-associated AKIAcute kidney injuryMulticenter cohort studyKidney function declineKidney functionKidney injuryCohort studyKidney outcomes of patientsIncidence of acute kidney injuryLong-term kidney outcomesHistorical cohort of patientsMultivariate time-to-event analysesPositive influenza ALongitudinal multicenter cohort studyWorsening kidney functionOutcomes of patientsAdverse kidney eventsCohort of patientsComposite of mortalityMarkers of illness severityAdult hospitalized patientsBaseline comorbidity scoreTime-to-event analysisFunctional decline
2023
Risk Prediction for Heart Failure Patients Admitted to the Intensive Care Unit Insights From REVeAL-HF
O’Connor K, Yamamoto Y, Sen S, Samsky M, Wilson F, Desai N, Ahmad T, Fuery M. Risk Prediction for Heart Failure Patients Admitted to the Intensive Care Unit Insights From REVeAL-HF. JACC Heart Failure 2023, 11: 727-728. PMID: 37052546, DOI: 10.1016/j.jchf.2023.01.021.Peer-Reviewed Original Research
2021
Prognostic Significance of Urinary Biomarkers in Patients Hospitalized with COVID-19
Menez S, Moledina D, Philbrook H, Wilson F, Obeid W, Simonov M, Yamamoto Y, villalobos C, Chang C, Garibaldi B, Clarke W, Farhadian S, Dela Cruz C, Coca S, Parikh C. Prognostic Significance of Urinary Biomarkers in Patients Hospitalized with COVID-19. Journal Of The American Society Of Nephrology 2021, 32: 107-107. DOI: 10.1681/asn.20213210s1107a.Peer-Reviewed Original ResearchAKI and Mortality in Patients Prescribed Immune Checkpoint Inhibitor Therapy
Baker M, Yamamoto Y, Perazella M, Parikh C, Wilson F, Moledina D. AKI and Mortality in Patients Prescribed Immune Checkpoint Inhibitor Therapy. Journal Of The American Society Of Nephrology 2021, 32: 132-132. DOI: 10.1681/asn.20213210s1132c.Peer-Reviewed Original ResearchAn Automated, Open-Source Program to Standardize AKI Definition from Time-Stamped Creatinine Data
Saran I, Aklilu A, Yamamoto Y, Biswas A, Wilson F. An Automated, Open-Source Program to Standardize AKI Definition from Time-Stamped Creatinine Data. Journal Of The American Society Of Nephrology 2021, 32: 115-115. DOI: 10.1681/asn.20213210s1115c.Peer-Reviewed Original Research
2020
Electronic Health Record Alerts for AKI: A MultiCenter Randomized Clinical Trial
Wilson F, Martin M, Yamamoto Y, Feldman H, Greenberg J, Mansour S, Moledina D, Palevsky P, Parikh C, Simonov M. Electronic Health Record Alerts for AKI: A MultiCenter Randomized Clinical Trial. Journal Of The American Society Of Nephrology 2020, 31: b3-b3. DOI: 10.1681/asn.20203110s1b3c.Peer-Reviewed Original Research